SPOTLIGHT: Novartis asthma drug gets OK from NICE

The UK's National Institute for Clinical Excellence has opened the gate for Novartis' Xolair to be used as an add-on treatment for severe allergic asthma in adults and adolescents. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.